Finoriq research workspace
ABBOTT LABORATORIES (ABT) SEC Filings & Filing Highlights
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Review ABT SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
- Company
- ABBOTT LABORATORIES (ABT)
- Ticker
- ABT
- Market Cap
- $176.8B
- Latest Price
- $101.48
- Industry
- Biotech & Pharma
ABBOTT LABORATORIES (ABT) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for ABBOTT LABORATORIES (ABT).
| Event | Form | Date |
|---|---|---|
| Abbott held its Annual Meeting of Shareholders on April 24, 2026. The following is a summary of...Abbott held its Annual Meeting of Shareholders on April 24, 2026. The following is a summary of the matters voted on at that meeting. (1) T... | 8-K5.07 | 2026-04-27 |
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K5.03 | 2026-04-27 |
| On April 24, 2026, Kevin Conroy was named to the Abbott Laboratories’ (“Abbott”) Board of Direc...On April 24, 2026, Kevin Conroy was named to the Abbott Laboratories’ (“Abbott”) Board of Directors. On April 24, 2026, Abbott shareholders... | 8-K5.02 | 2026-04-27 |
| On April 16, 2026, Abbott Laboratories announced its results of operations for the first quarte...On April 16, 2026, Abbott Laboratories announced its results of operations for the first quarter 2026 | 8-K2.02 | 2026-04-16 |
| IN THE UNITED STATES DISTRICT COURTThis notice (the “Notice”) advises you of the proposed settlement (the “Settlement”) of derivative claims brought against certain current a... | 8-K8.01 | 2026-04-17 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.